19th Oncology Update: Advances and Controversies

LIVE
19th Oncology Update: Advances and Controversies Banner

Add to Calendar 19th Oncology Update: Advances and Controversies 1/13/2023 7:10:00 AM 1/16/2023 7:30:00 PM America/Denver For More Details: https://mdanderson.cloud-cme.com/AdvancesAndControversies2023 Description: The treatment of solid tumors continues to evolve and clinicians must stay abreast of the current information and recent therapeutic advances. Many tumor types require multidisciplinary treatment; many therapies previously studied only in advanced and metastatic settings are now applied in early curative stages as well. Healthcare professionals who care for cancer patients in different stages of dise... Steamboat Grand Hotel false MM/DD/YYYY


Date & Location
Friday, January 13, 2023, 7:10 AM - Monday, January 16, 2023, 7:30 PM, Steamboat Grand Hotel, Steamboat Springs, CO

Target Audience
Specialties - Pathology, Radiation Oncology
Professions - Physician (MD or DO)

Credits
AMA PRA Category 1 Credits™ (30.00 hours), Medical Ethics/Professional Responsibility (1.25 hours), Non-Physician Attendance (30.00 hours)

Overview
The treatment of solid tumors continues to evolve and clinicians must stay abreast of the current information and recent therapeutic advances. Many tumor types require multidisciplinary treatment; many therapies previously studied only in advanced and metastatic settings are now applied in early curative stages as well. Healthcare professionals who care for cancer patients in different stages of disease need to understand the basis for these therapies. Additionally, HCPs must apply the preclinical and clinical data supporting the development and integration of these new therapies into their clinical practice. This educational conference will interactively address current management controversies, updates, and novel therapies for multiple tumor types. It will bring together experts from multiple disciplines involved in the treatment of various solid tumors. The expected outcome is further integration of new cancer care developments into the clinical practice of surgeons, medical oncologists, radiation oncologists, and allied healthcare professionals who care for cancer patients.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Utilize an appropriate sequence for surgical, radiation and chemotherapeutic intervention into the treatment of head & neck cancer, gastrointestinal malignancies, melanoma, lung cancer, breast cancer, gynecologic cancer, and genitourinary cancers.
  2. Describe and apply an optimal treatment approach when given patient scenarios representing a range of disease stages, clinical presentations and comorbidities.
  3. Incorporate preventive, screening and symptom control modalities in oncology care.
  4. Identify patients who will appropriately benefit from novel therapies in the treatment of solid tumors.
  5. Utilize the different surgical, radiation, and systemic treatments including immunotherapies and molecular-targeted therapies for cancers at varying stages of disease.

Registration

Registration on-site is available.

On-site registration for the 19th Annual Oncology Update: Advances and Controversies, will open at 6:30 am on Friday, January 13, 2023, and the conference will begin at 7:00 am.  The conference will adjourn at 8:15 pm on Monday, January 16, 2023.  Advanced registration is encouraged as space and materials are limited.  Please see registration form for applicable fees.

Advanced registration is encouraged. The deadline for advanced registration is January 3, 2023.

Fees:

REGISTRATION CATEGORY

BEFORE
Jan. 3

AFTER
Jan 3
 Physicians/Scientists (MD, PhD)  $600  $650
 MD Anderson Faculty  $375  $400
 Fellows, PAs, Nurses, Social Workers, etc.  $275  $300
 Guest Rate  $150  $150



We accept the following forms of payment:
  •Credit Cards (MasterCard, VISA, and American Express)
  •Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
   Continuing Professional Education (CPE) – Unit 1781
   The University of Texas MD Anderson Cancer Center
   P.O. Box 301407
   Houston, Texas 77230-1407

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on your profile during the process. 

Telephone registrations are not accepted.

Refund/Cancellation Policy
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before January 3, 2023.  No refunds will be granted after this date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Special Assistance
For additional information or Special Assistance, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]

 
Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status.  Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.  The survey link will be provided during the course.


Accreditation
Accreditation/Credit Designation - Physicians
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 31.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.